Renal toxicity of anticancer agents targeting HER2 and EGFR-Reference-Cited by-同舟云学术

Renal toxicity of anticancer agents targeting HER2 and EGFR

Published:2015-09-04 Issue:6 Volume:28 Page:647-657
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Cosmai Laura,Gallieni Maurizio,Porta Camillo

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-015-0226-9.pdf

Reference79 articles.

1. Coussens L, Yang-Feng T, Liao Y et al (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139

2. Olayioye M (2001) Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res 3:385–389

3. Mitri Z, Constantine T, O’Regan R (2012) The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy. Chemother Res Pract 2012:743193

4. Burstein H (2005) The distinctive nature of HER2-positive breast cancers. N Engl J Med 353:1652–1654

5. Roy V, Perez E (2009) Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist 14:1061–1069

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog Model;Toxins;2024-08-26

2. Nephrotoxicity of targeted therapy used to treat lung cancer;Frontiers in Immunology;2024-07-04

3. Pharmacotherapy considerations in patients who develop acute kidney injury during anti-cancer therapy;Expert Opinion on Pharmacotherapy;2024-03-23

4. The renal damage and mechanisms relevant to antitumoral drugs;Frontiers in Oncology;2023-12-12

5. Tumor Markers as Predictors of Acute Kidney Injury Incidence and Staging of the Muscle-Invasive Bladder Cancer Receiving Chemoradiation Therapy;World Journal of Oncology;2023-10